MGTX vs. BHC, BEAM, ARQT, BHVN, SDGR, EWTX, JANX, ETNB, ADPT, and DYN
Should you be buying MeiraGTx stock or one of its competitors? The main competitors of MeiraGTx include Bausch Health Companies (BHC), Beam Therapeutics (BEAM), Arcutis Biotherapeutics (ARQT), Biohaven (BHVN), Schrödinger (SDGR), Edgewise Therapeutics (EWTX), Janux Therapeutics (JANX), 89bio (ETNB), Adaptive Biotechnologies (ADPT), and Dyne Therapeutics (DYN). These companies are all part of the "pharmaceutical products" industry.
MeiraGTx vs. Its Competitors
MeiraGTx (NASDAQ:MGTX) and Bausch Health Companies (NYSE:BHC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment, valuation and community ranking.
67.5% of MeiraGTx shares are owned by institutional investors. Comparatively, 78.7% of Bausch Health Companies shares are owned by institutional investors. 7.5% of MeiraGTx shares are owned by insiders. Comparatively, 8.1% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Bausch Health Companies received 166 more outperform votes than MeiraGTx when rated by MarketBeat users. However, 71.59% of users gave MeiraGTx an outperform vote while only 60.91% of users gave Bausch Health Companies an outperform vote.
MeiraGTx has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500.
Bausch Health Companies has a net margin of -0.48% compared to MeiraGTx's net margin of -633.05%. MeiraGTx's return on equity of -146.38% beat Bausch Health Companies' return on equity.
In the previous week, MeiraGTx had 3 more articles in the media than Bausch Health Companies. MarketBeat recorded 6 mentions for MeiraGTx and 3 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 1.45 beat MeiraGTx's score of 1.17 indicating that Bausch Health Companies is being referred to more favorably in the news media.
MeiraGTx presently has a consensus target price of $24.00, suggesting a potential upside of 270.37%. Bausch Health Companies has a consensus target price of $7.42, suggesting a potential upside of 39.28%. Given MeiraGTx's stronger consensus rating and higher probable upside, analysts plainly believe MeiraGTx is more favorable than Bausch Health Companies.
Bausch Health Companies has higher revenue and earnings than MeiraGTx. Bausch Health Companies is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks.
Summary
MeiraGTx and Bausch Health Companies tied by winning 9 of the 18 factors compared between the two stocks.
Get MeiraGTx News Delivered to You Automatically
Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MeiraGTx Competitors List
Related Companies and Tools
This page (NASDAQ:MGTX) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy MGTX Stock Free MGTX Stock Alerts